Medication info
Pimaduet Tablet 60/2.5 mg

Pimaduet Tablet 60/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Yellow, rounded square, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300122 · Approved 2023.01.06 · Insurance code 663608700

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, direct switching to this medicine may be considered if blood pressure is not controlled, as follows. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication helps to control blood pressure more effectively in patients with essential hypertension whose blood pressure is not adequately controlled with Pimasartan Potassium monotherapy. It acts by dilating blood vessels to reduce blood pressure and can improve blood pressure control as combination therapy in cases where monotherapy is insufficient. Hence, Pimasartan Potassium is used in the management of blood pressure in essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, direct switching to this medicine may be considered if blood pressure is not controlled, as follows. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals with an allergy to its active ingredients or similar substances, those who are pregnant or nursing, patients undergoing dialysis, those with moderate to severe liver impairment, patients with bile duct obstruction, certain kidney diseases, or diabetic nephropathy. Caution is required for individuals with low blood volume or salt deficiency, impaired kidney function, renovascular hypertension, heart valve diseases, severe hypotension, elderly patients, or those sensitive to specific dyes. Symptoms such as dizziness, headache, facial swelling, urinary disorders, insomnia, and flushing may occur during use, and rare but serious side effects may emerge; consult a healthcare professional immediately if any abnormal symptoms arise. In cases of hypotension or electrolyte imbalance, blood pressure may drop sharply, especially during the initial dose; therefore, close monitoring is required. This medication may interact with other antihypertensives, diuretics, potassium-sparing diuretics, certain antibiotics, analgesics, etc., so it is important to inform your healthcare provider about any concurrent medications. If pregnant or nursing, this medication should be avoided or taken only after consulting a doctor to determine the necessity of use. Safety and efficacy in children under 18 years have not been established; therefore, it is advisable not to use it in this age group. In cases of overdose, severe hypotension, cardiac arrhythmias, etc., may occur, necessitating immediate emergency treatment, and self-treatment should be avoided. Keep this medication out of the reach of children, and be careful not to transfer it to another container, as this may compromise quality and increase the risk of accidents. Dizziness or drowsiness may occur when driving or operating dangerous machinery during treatment, so caution is advised. Patients with heart failure or impaired liver function require special caution when taking this medication, and dosage adjustments may be necessary based on their condition.

Side effects

  • Dizziness
  • positional dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urination disorder
  • insomnia
  • flushing
  • fainting
  • sedation
Show 131 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • epigastric pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • exacerbation of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified type
  • cervical cancer
  • prostate cancer
  • acute kidney failure
  • chronic kidney failure
  • kidney stones
  • pyelonephritis
  • incontinence
  • rhinitis
  • fibrotic alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthrosis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • cerebral infarction
  • fracture
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain/loss
  • tension
  • sensory reduction
  • sensory abnormalities
  • peripheral neuropathy
  • taste abnormalities
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • cough
  • dyspnea
  • rhinitis
  • hair loss
  • sweating
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • rash
  • vascular edema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin flushing
  • papular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that protects it from light and air, at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Yellow, rounded square, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.